Serious liver disease induced by infliximab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serious liver disease induced by infliximab

Published:2006-03-18 Issue:4 Volume:26 Page:578-581
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Tobon Gabriel J.,Cañas Carlos,Jaller Juan-Jose,Restrepo Juan-Carlos,Anaya Juan-Manuel

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s10067-005-0169-y.pdf

Reference17 articles.

1. Knight DM, Trinh H, Le J et al (1993) Construction and initial characterization of a mouse–human chimeric anti-TNF antibody. Mol Immunol 30:1443–1453

2. Present DH, Rutgeerts P, Targan S et al (1999) Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Eng J Med 340:1398–1405

3. Lipsky PE, van de Heijde DMFM, St Clair EW et al (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Eng J Med 343:1594–1602

4. Saleem G, Li Shuan, MacPherson BR et al (2001) Hepatitis with interfase inflammation and IgG, IgM, and IgA anti-double-stranded DNA antibodies following infliximab therapy: comment on article by Charles et al. Arthritis Rheum 44:1966–1968

5. Menghini V, Arora A (2001) Infliximab-associated reversible cholestatic liver disease. Mayo Clin Proc 76:84–86

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Certolizumab-Induced Liver Injury in Ankylosing Spondylitis: A Case Report and Causality Assessment;Cureus;2024-08-10

2. Infliximab in steroid-refractory immune-related hepatitis does not demonstrate hepatotoxicity and may shorten time on steroids;Journal for ImmunoTherapy of Cancer;2024-07

3. Enhancing the Efficacy and Safety of Methotrexate Treatment: A Focus on Drug Interactions (Review);Safety and Risk of Pharmacotherapy;2024-04-27

4. Low ALT Is Associated with IBD and Disease Activity: Results from a Nationwide Study;Journal of Clinical Medicine;2024-03-24

5. Non-alcoholic fatty liver disease and psoriasis: mechanisms of comorbidity and approaches to therapy;Meditsinskiy sovet = Medical Council;2024-03-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3